The UK’s Advanced Research and Invention Agency (ARIA) has launched a study exploring why queen bees live significantly longer than worker bees, with preliminary results suggesting potential human applications. Researchers found that a specific peptide in royal jelly, which queen bees consume exclusively, extends their lifespan by 5-6 times when injected into regular bees. Human trials reportedly show unexpected benefits, including increased height and improved reproductive health.

Queen bees share identical DNA with worker bees but live up to 20 times longer. Scientists attribute this to the unique composition of royal jelly, which is lower in sugar and richer in vitamins, nutrients, and fatty acids compared to the honey and pollen consumed by workers. The substance also contains antioxidant and anti-inflammatory properties. A study published in Applied and Environmental Microbiology noted that queen bees may delay aging by reducing oxidative damage through mechanisms like inhibiting insulin signaling.

Harvesting royal jelly is labor-intensive, requiring beekeepers to create queenless colonies and manually extract the substance, a process criticized as unethical by some. Meanwhile, a product called the Aeon patch claims to mimic the effects of the peptide in royal jelly, with manufacturers asserting it can activate similar biological processes in humans. The patch, priced at $2.33 per unit, is marketed as an alternative to consuming large quantities of royal jelly, which would cost over $800 for 30 cups.

The research team emphasized that the findings could revolutionize approaches to aging, fertility, and disease prevention. However, no medical claims are made about the patch, as required by law. The study remains focused on understanding natural biological mechanisms rather than commercial applications.